In today’s briefing:
- Mitsubishi Logisnext (7105) – The Next Target in Logistics Space?
- Frontier Management Inc. (7038 JP) – Q3 Follow-Up
- Medical Data Vision Co., Ltd (4971 JP): Research Update
Mitsubishi Logisnext (7105) – The Next Target in Logistics Space?
- A Nikkei article this morning several hours pre-open said that Mitsubishi Heavy Industries (7011 JP) was preparing to sell its listed forklift subsidiary Mitsubishi Logisnext Co., Ltd. (7105 JP).
- The story says “Investors had been pressuring Mitsubishi Heavy to spin off or delist Logisnext” and we know the TSE dislikes dual listings. I would have expected a buy-in but…
- There are a number of reasons why a buyer could find this asset attractive. I suggest reading all the way through and the tone of the Conclusions.
Frontier Management Inc. (7038 JP) – Q3 Follow-Up
- Frontier Management Inc. (hereafter, the Company) announced Q3 FY2024/12 results on November 13, 2024.
- Cumulative Q3 sales in the Management Consulting Business remained strong at JPY 4,444 mn (+18.1% YoY), but other segments suffered.
- The Revitalization Support Business posted sales of JPY 1,088 mn (-15.0% YoY), reflecting the completion of a major project.
Medical Data Vision Co., Ltd (4971 JP): Research Update
- MDV revised down its full-year FY24 guidance (discussed in more details on p.5) given the Q3 result [Q1~Q3 gross profit [GP] of ¥3,055mil (-12.8% YoY), operating loss of -¥140mil (vs FY23 Q3 OP of ¥1,111mil) on sales of ¥4,125mil (-8.1% YoY)], due to (1) the delay to the onboarding of the firm’s cloud-based health check system solution Alpha Salus as the debugging process continued through to September, and (2) a delay in mobilising potential users of the new content (no-contact vital sensing for cats) for MDV’s personal health management app Karteco, as the planned large-scale advertising campaign was pushed back following a delay in the launch of the content.
- The firm is guiding for FY24 annual dividend of ¥6.5/share (unchanged from FY23) and generates a dividend pay-out ratio of 138.0% based on the revised FY24 EPS forecast of ¥4.71.